Cellectar, Novelos deal

Cancer company Novelos acquired radiopharmaceutical company Cellectar in a stock deal valued at $64.4 million based on Novelos' close of

Read the full 202 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE